InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (61 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
61
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Azamian Bobak R., Chief Executive Officer. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. In total, 63 reports have been logged. Split: 0 buy · 61 sells. Total volume traded: €5.4m. Activity tracked since 5 August 2021. The latest transaction was filed on 24 December 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations63 total
4,582 sharesCommon StockSEC:0001827672-26-000009:0
5,418 sharesCommon StockSEC:0001827672-26-000009:1
5,443 shares@ US$82.417.1% of flowCommon StockSEC:0001827672-25-000007:0
557 shares@ US$83.540.7% of flowCommon StockSEC:0001827672-25-000007:1
6,000 shares@ US$50.005.1% of flowCommon StockSEC:0001819790-25-000061:0
7,131 shares@ US$46.295.6% of flowCommon StockSEC:0001819790-25-000055:0
51,395 sharesCommon StockSEC:0001819790-25-000046:0
28,274 sharesCommon StockSEC:0001819790-24-000045:0
8,000 shares@ US$20.222.7% of flowCommon StockSEC:0001827672-23-000050:0
9,443 shares@ US$19.963.2% of flowCommon StockSEC:0001827672-23-000048:0
2,896 shares@ US$18.010.9% of flowCommon StockSEC:0001827672-23-000045:0
8,000 shares@ US$13.241.9% of flowCommon StockSEC:0001827672-23-000043:0
8,000 shares@ US$17.213.3% of flowCommon StockSEC:0001827672-23-000041:0
8,000 shares@ US$17.232.4% of flowCommon StockSEC:0001827672-23-000039:0
4,174 shares@ US$19.281.3% of flowCommon StockSEC:0001827672-23-000037:0
9,000 shares@ US$17.352.6% of flowCommon StockSEC:0001827672-23-000035:0
8,000 shares@ US$18.632.5% of flowCommon StockSEC:0001819790-23-000048:0
9,000 shares@ US$18.582.9% of flowCommon StockSEC:0001827672-23-000033:0
3,100 shares@ US$20.011.1% of flowCommon StockSEC:0001209191-23-036433:0
8,000 shares@ US$15.902.2% of flowCommon StockSEC:0001827672-23-000031:0
9,000 shares@ US$16.802.6% of flowCommon StockSEC:0001827672-23-000030:0
4,278 shares@ US$15.131.1% of flowCommon StockSEC:0001827672-23-000028:0
5,841 shares@ US$15.101.5% of flowCommon StockSEC:0001827672-23-000028:1
2,311 shares@ US$15.030.6% of flowCommon StockSEC:0001827672-23-000026:0
8,000 shares@ US$13.601.8% of flowCommon StockSEC:0001827672-23-000024:0
25 of 63 declarations
About Azamian Bobak R.
Bobak R. Azamian is an executive at Tarsus Pharmaceuticals, Inc.
